v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF TEMPORARY REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Temporary Redeemable Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2022 $ 64,131          
Beginning balance, shares at Dec. 31, 2022 3,941,980          
Temporary Redeemable Preferred Stock            
Cancellation of NCNV1 preferred stock $ (67,034)          
Cancellation of NCNV1 preferred stock, shares (67,034)          
Issuance of NCNV 2 preferred stock $ 103,952          
Issuance of NCNV preferred stock, shares 103,952          
Ending balance at Dec. 31, 2023 $ 106,952          
Ending balance, shares at Dec. 31, 2023 3,978,898          
Balance beginning at Dec. 31, 2022     $ 144,777 $ 164 $ (256,541) $ (111,600)
Balance beginning, shares at Dec. 31, 2022   167,666        
Stockholders' deficit            
Stock based compensation     1     1
Issuance of common stock from options exercised     3     3
Issuance of common stock from options exercised, shares   6,411        
Net loss         (13,036) (13,036)
Foreign currency translation adjustments       64   64
Balance ending at Dec. 31, 2023     138,878 228 (269,577) $ (130,471)
Balance ending, shares at Dec. 31, 2023   174,077       174,077
Temporary Redeemable Preferred Stock            
Cancellation of NCNV1 preferred stock $ (562)          
Cancellation of NCNV1 preferred stock, shares (562)          
Reduction of the original issue price from $1,000 to $600 per share $ (43,656)          
Issuance of NCNV 2 preferred stock $ 5,752          
Issuance of NCNV preferred stock, shares 5,752          
Ending balance at Sep. 30, 2024 $ 68,486          
Ending balance, shares at Sep. 30, 2024 3,984,088          
Stockholders' deficit            
Stock based compensation     7,401     $ 7,401
Issuance of common stock from options exercised     34     34
Reduction of the original issue price of NCNV preferred share value from $1,000 to $600 per share     43,656     43,656
Net loss         (17,197) (17,197)
Foreign currency translation adjustments       (35)   (35)
Balance ending at Sep. 30, 2024     189,969 193 (286,774) $ (96,612)
Balance ending, shares at Sep. 30, 2024   174,077        
Beginning balance at Dec. 31, 2023 $ 106,952          
Beginning balance, shares at Dec. 31, 2023 3,978,898          
Temporary Redeemable Preferred Stock            
Cancellation of NCNV1 preferred stock $ (562)          
Cancellation of NCNV1 preferred stock, shares (562)          
Reduction of the original issue price from $1,000 to $600 per share $ (43,656)          
Issuance of NCNV 2 preferred stock $ 5,752          
Issuance of NCNV preferred stock, shares 5,752          
Ending balance, shares at Dec. 31, 2024           0
Balance beginning at Dec. 31, 2023     138,878 228 (269,577) $ (130,471)
Balance beginning, shares at Dec. 31, 2023   174,077       174,077
Stockholders' deficit            
Stock based compensation     7,735     $ 7,735
Issuance of common stock from options exercised     34     34
Issuance of common stock from options exercised, shares   14,841        
Reduction of the original issue price of NCNV preferred share value from $1,000 to $600 per share     43,656     43,656
Issuance of common stock for note conversions           5,882
Net loss         (20,823) (20,823)
Foreign currency translation adjustments       101   101
Balance ending at Dec. 31, 2024     275,383 329 (290,400) $ (14,688)
Balance ending, shares at Dec. 31, 2024   22,849,378       22,849,378
Beginning balance at Jun. 30, 2024 $ 112,142          
Beginning balance, shares at Jun. 30, 2024 3,984,088          
Temporary Redeemable Preferred Stock            
Reduction of the original issue price from $1,000 to $600 per share $ (43,656)          
Ending balance at Sep. 30, 2024 $ 68,486          
Ending balance, shares at Sep. 30, 2024 3,984,088          
Balance beginning at Jun. 30, 2024     146,228 339 (286,570) $ (140,003)
Balance beginning, shares at Jun. 30, 2024   174,077        
Stockholders' deficit            
Stock based compensation     51     51
Issuance of common stock from options exercised     34     34
Reduction of the original issue price of NCNV preferred share value from $1,000 to $600 per share     43,656     43,656
Net loss         (204) (204)
Foreign currency translation adjustments       (146)   (146)
Balance ending at Sep. 30, 2024     189,969 193 (286,774) $ (96,612)
Balance ending, shares at Sep. 30, 2024   174,077        
Beginning balance, shares at Dec. 31, 2024           0
Ending balance, shares at Sep. 30, 2025           0
Balance beginning at Dec. 31, 2024     275,383 329 (290,400) $ (14,688)
Balance beginning, shares at Dec. 31, 2024   22,849,378       22,849,378
Stockholders' deficit            
Stock based compensation     5,192     $ 5,192
Issuance of common stock from options exercised     157     $ 157
Issuance of common stock from options exercised, shares   100,274       100,274
Issuance of common stock for note conversions     3,907     $ 3,907
Issuance of common stock for note conversions, shares   1,421,874        
Issuance of restricted stock units     390     390
Issuance of restricted stock units, shares   173,781        
Issuance of common stock under equity line of credit     3,605     $ 3,605
Issuance of common stock under equity line of credit, shares   1,937,141       1,937,141
Net loss         (18,103) $ (18,103)
Foreign currency translation adjustments       (145)   (145)
Balance ending at Sep. 30, 2025     288,634 184 (308,503) $ (19,685)
Balance ending, shares at Sep. 30, 2025   26,482,448       26,482,448
Ending balance, shares at Sep. 30, 2025           0
Balance beginning at Jun. 30, 2025     279,840 198 (302,334) $ (22,296)
Balance beginning, shares at Jun. 30, 2025   23,220,141        
Stockholders' deficit            
Stock based compensation     2,364     2,364
Issuance of common stock from options exercised     72     72
Issuance of common stock from options exercised, shares   15,514        
Issuance of common stock for note conversions     2,375     2,375
Issuance of common stock for note conversions, shares   1,139,204        
Issuance of restricted stock units     378     378
Issuance of restricted stock units, shares   170,448        
Issuance of common stock under equity line of credit     3,605     3,605
Issuance of common stock under equity line of credit, shares   1,937,141        
Net loss         (6,169) (6,169)
Foreign currency translation adjustments       (14)   (14)
Balance ending at Sep. 30, 2025     $ 288,634 $ 184 $ (308,503) $ (19,685)
Balance ending, shares at Sep. 30, 2025   26,482,448       26,482,448